P/E ratio for Psychemedics (PMD)
P/E ratio as of April 2024 (TTM): -7.48
According to Psychemedics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.4757. At the end of 2022 the company had a P/E ratio of -25.6.
P/E ratio history for Psychemedics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -25.6 | -52.51% |
| 2021 | -54.0 | 640.39% |
| 2020 | -7.29 | -122.29% |
| 2019 | 32.7 | 71.71% |
| 2018 | 19.1 | 3.59% |
| 2017 | 18.4 | -8.49% |
| 2016 | 20.1 | -44.5% |
| 2015 | 36.2 | 43.42% |
| 2014 | 25.3 | 23.76% |
| 2013 | 20.4 | 8.18% |
| 2012 | 18.9 | 38.86% |
| 2011 | 13.6 | -15.53% |
| 2010 | 16.1 | -36.56% |
| 2009 | 25.3 | 123.63% |
| 2008 | 11.3 | -39.27% |
| 2007 | 18.7 | -7.9% |
| 2006 | 20.3 | 14.53% |
| 2005 | 17.7 | -24.86% |
| 2004 | 23.5 | -39.69% |
| 2003 | 39.0 | 163.63% |
| 2002 | 14.8 | -92.78% |
| 2001 | 205 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 19.9 | -366.02% | 🇺🇸 USA |
 LabCorp LH | 26.4 | -452.83% | 🇺🇸 USA |
 RadNet RDNT | -211 | 2,720.15% | 🇺🇸 USA |
 NeoGenomics
NEO | -15.4 | 106.25% | 🇺🇸 USA |
 Enzo Biochem ENZ | -1.12 | -84.99% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.